Webinar: How States Pay for Hep C Drugs Using a “Netflix-style” Subscription Model

A Look at Emerging Payment Models and Patient-Centered Outcomes Research
Wednesday, May 15, 2019
3 p.m. (ET)
Download slides.

Faced with costly and effective treatment for hepatitis C, states are exploring innovative alternative payment methodologies (APMs) to expand access to treatment and generate savings. Using a “Netflix-style” subscription model, Louisiana and Washington are negotiating agreements with drug manufacturers to get unlimited access to hepatitis C drugs for a fixed, predetermined cost. Join this NASHP webinar to hear about Louisiana and Washington’s innovative APMs as well as related research into hepatitis C from the Patient-Centered Outcomes Research Institute (PCORI).

Moderator: Trish Riley, Executive Director, National Academy for State Health Policy


  • Pete Croughan, Health Policy Advisor, Louisiana Department of Public Health
  • Donna Sullivan, MS, PharmD, Chief Pharmacy Officer, Washington Health Care Authority
  • Robyn Liu, MD, MPH, Assistant Professor of Family Medicine, School of Medicine, Oregon Health and Science University